Compounds > 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Page last updated: 2024-08-23

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Lung Diseases

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Lung Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Croccia, C; de Matos, HJ; Lopes, AJ; Nunes, RA; Pinto, LF; Sabaa-Srur, AU; Silva, AC; Tessarollo, B; Trotte, MN; Vaz, LC1

Other Studies

1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Lung Diseases

ArticleYear
Royal sun medicinal mushroom Agaricus brasiliensis (higher Basidiomycetes) and the attenuation of pulmonary inflammation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    International journal of medicinal mushrooms, 2013, Volume: 15, Issue:4

    Topics: Agaricus; Animals; Anti-Inflammatory Agents, Non-Steroidal; Inflammation; Lung Diseases; Male; Nitrosamines; Rats; Rats, Wistar

2013